Prospectus

Zhibao Technology Inc. Announces Closing of Initial Public Offering

Retrieved on: 
Wednesday, April 3, 2024

Shanghai, China, April 03, 2024 (GLOBE NEWSWIRE) -- Zhibao Technology Inc. (Nasdaq: “ZBAO” or the “Company”), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced the closing of its initial public offering ("Offering”) of 1,500,000 Class A ordinary shares at a public offering price of $4.00 per Class A ordinary share for aggregate gross proceeds of $6,000,000, before deducting underwriting discounts and offering expenses.

Key Points: 
  • Shanghai, China, April 03, 2024 (GLOBE NEWSWIRE) -- Zhibao Technology Inc. (Nasdaq: “ZBAO” or the “Company”), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced the closing of its initial public offering ("Offering”) of 1,500,000 Class A ordinary shares at a public offering price of $4.00 per Class A ordinary share for aggregate gross proceeds of $6,000,000, before deducting underwriting discounts and offering expenses.
  • The Company has granted the underwriters a 45-day option to purchase up to an additional 225,000 Class A ordinary shares to cover the over-allotment at the public offering price, less underwriting discounts and commissions.
  • The Class A ordinary shares began trading on the Nasdaq Capital Market on April 2, 2024 under the symbol "ZBAO."
  • In addition, a copy of the final prospectus relating to the Offering may be obtained via the SEC's website at www.sec.gov .

Premium Income Corporation Announces Quarterly Distribution

Retrieved on: 
Wednesday, April 3, 2024

To the extent that any portion of the distributions are ordinary taxable dividends and not capital gains dividends, they will be eligible dividends.

Key Points: 
  • To the extent that any portion of the distributions are ordinary taxable dividends and not capital gains dividends, they will be eligible dividends.
  • For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172, email at [email protected] or visit www.mulvihill.com
    Commissions, trailing commissions, management fees and expenses all may be associated with investment funds.
  • Please read the prospectus before investing.
  • Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.

Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Retrieved on: 
Wednesday, April 3, 2024

The gross proceeds of the offering of shares, before deducting placement agent’s fees and other offering expenses, were approximately $6,000,000.

Key Points: 
  • The gross proceeds of the offering of shares, before deducting placement agent’s fees and other offering expenses, were approximately $6,000,000.
  • H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
  • The offering of the shares of common stock was made only by means of a prospectus, including a prospectus supplement, forming a part of an effective registration statement.
  • A prospectus supplement and accompanying prospectus relating to the offering of shares of common stock was filed with the SEC.

Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class

Retrieved on: 
Wednesday, April 3, 2024

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly cash distribution for its ETF Class in the amount of $0.05417 per unit, payable on May 7, 2024 to unitholders of record on April 30, 2024.

Key Points: 
  • TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly cash distribution for its ETF Class in the amount of $0.05417 per unit, payable on May 7, 2024 to unitholders of record on April 30, 2024.
  • For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172, email at [email protected] or visit www.mulvihill.com .
  • Commissions, trailing commissions, management fees and expenses all may be associated with investment funds.
  • Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution

Retrieved on: 
Wednesday, April 3, 2024

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on May 7, 2024 to unitholders of record on April 30, 2024.

Key Points: 
  • TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on May 7, 2024 to unitholders of record on April 30, 2024.
  • For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172, email at [email protected] or visit www.mulvihill.com .
  • Commissions, trailing commissions, management fees and expenses all may be associated with investment funds.
  • Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.

S Split Corp. Declares Monthly Distribution

Retrieved on: 
Wednesday, April 3, 2024

To the extent that any portions of the distributions are ordinary taxable dividends and not capital gain dividends, they are eligible dividends.

Key Points: 
  • To the extent that any portions of the distributions are ordinary taxable dividends and not capital gain dividends, they are eligible dividends.
  • For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172, email at [email protected] or visit www.mulvihill.com .
  • Commissions, trailing commissions, management fees and expenses all may be associated with investment funds.
  • Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.

HSBC Continental Europe: Pre Stabilisation Notice

Retrieved on: 
Wednesday, April 3, 2024

However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

Key Points: 
  • However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.
  • Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.
  • This announcement is not an offer of securities for sale into the United States.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Retrieved on: 
Wednesday, April 3, 2024

SALT LAKE CITY, UT, April 03, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, today announced the pricing of its previously announced public offering of 71,600,000 shares of its common stock at a public offering price of $0.021 per share.

Key Points: 
  • SALT LAKE CITY, UT, April 03, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, today announced the pricing of its previously announced public offering of 71,600,000 shares of its common stock at a public offering price of $0.021 per share.
  • Gross proceeds from the offering are expected to be approximately $1.5 million before deducting placement agent fees and estimated offering expenses.
  • SINTX intends to use the net proceeds of the offering, if any, for working capital and general corporate purposes.
  • The public offering is being made pursuant to an effective shelf registration statement on Form S-3, as amended (File No.

Matinas BioPharma Prices $10 Million Registered Direct Offering

Retrieved on: 
Wednesday, April 3, 2024

The gross proceeds of the offering will be approximately $10 million before deducting fees and other estimated offering expenses.

Key Points: 
  • The gross proceeds of the offering will be approximately $10 million before deducting fees and other estimated offering expenses.
  • The closing of the offering is expected to take place on or about April 5, 2024, subject to the satisfaction of customary closing conditions.
  • The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.
  • A final prospectus supplement and accompanying base prospectus relating to the offering will be filed by Matinas BioPharma with the SEC.

YieldMax™ ETFs Announces Monthly Distributions on MSTY (120.57%), CONY (119.30%), NVDY (106.86%), AMDY (65.04%), FBY (61.10%) and Others

Retrieved on: 
Wednesday, April 3, 2024

The Distribution Rate is calculated by multiplying an ETF’s Distribution per Share by twelve (12), and dividing the resulting amount by the ETF’s most recent NAV.

Key Points: 
  • The Distribution Rate is calculated by multiplying an ETF’s Distribution per Share by twelve (12), and dividing the resulting amount by the ETF’s most recent NAV.
  • The Distribution Rate and 30-Day SEC Yield are not indicative of future distributions, if any, on the ETFs.
  • Distributions for the ETFs (if any) are variable and may vary significantly from month to month and may be zero.
  • If the Fund does make distributions, the amounts of such distributions will likely vary greatly from one distribution to the next.